Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
5 raisons identifiées
Auteur de référence en rhumatologie
22 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 10 fois dans les médias — pédagogie reconnue
Expérience confirmée
35 ans d'exercice en rhumatologie — recul clinique solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
35ans d'exercice (thèse 1991)
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
22
22 articles ont été cités au moins 22fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
1 713
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
79
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
38
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Centre hospitalier national d'ophtalmologie des Quinze-Vingts
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Efficacy and safety of preserflo™ microshunt in refractory ocular hypertension with or without secondary glaucoma following pars plana vitrectomy
2025ArticleGraefe's Archive for Clinical and Experimental Ophthalmology
The Effect of Selective Laser Trabeculoplasty on Intraocular Pressure in Patients with Dexamethasone Intravitreal Implant-Induced Elevated Intraocular Pressure
2020ArticleJournal of Ophthalmology
Cataract and glaucoma combined surgery: XEN® gel stent versus nonpenetrating deep sclerectomy, a pilot study.
2020ArticleBMC Ophthalmology
Complications of cosmetic iris implants: French series of 87 eyes
2020ArticleJournal of Cataract and Refractive Surgery
Cyclocoagulation of the ciliary bodies by high-intensity focused ultrasound: A 12-month multicenter study
2015ArticleInvestigative Ophthalmology & Visual Science
Multicenter clinical trial of ultrasonic circular cyclo coagulation in patients with open-angle glaucoma: One year results
2014CongrèsAnnual meeting of the association for research in vision and ophthalmology (ARVO)
Glaucoma medications, preservatives and the ocular surface
2014ArticleJournal Français d'Ophtalmologie
Ultrasonic circular cyclo coagulation in patients with primary open-angle glaucoma: A multicenter clinical trial
2013CongrèsEuropean Association for Vision and Eye Research (EVER) Congress
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CABINET DU DR JEAN-PHILIPPE NORDMANN
28 RUE DE CHARENTON, 75012 PARIS
CHNO DES QUINZE VINGTS PARIS
28 R DE CHARENTON, 75571 PARIS CEDEX 12
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Le360 · 03/10/2017
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNGUwV1R2bERPbjVnSzhLVUlDQUg2dnhIdVlaaEV0SGotZmdxYlQwVWhZbC0wUVBBQWRjTWhJek1YUklUUERJZlJBSnhac1RvRWR3Z0ZmRVZZUjI2d25Ja253RUx1UTZXaE5xNHBOOHUyOWRGcFMtaVNreTRMLXFmb2FQRFRPVVgwXzhzd1ZuYmVubHQ4WnhTVVZqbTBGTzR1eFNGT1AxUGQ?oc=5" target="_blank">
📰 Bladi.net · 21/09/2017
<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFB1MnJWZXpRNU82OFA2ZnFsWHVid0g5cUhrQTFydlAxc1l2em1LOC1IX0pDT2twM0diNjI0OXNRcG4xWTNwNHpCYWIxalQySGZEVGtCUnFhYmFRaUVscGtVS3Npakw2UQ?oc=5" target="_blank">Photo : Mohammed VI, Moulay Ismaïl et Teddy Riner</a> <font color="#6f6f6f">Bladi.net</fo
📰 Plurielle Magazine · 09/09/2017
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxORnNKTlJVdEZ5UGlIZnVZRVFRUFFoSUluMTA0djNzQ2pJVGdPUmx2UG5YTmxmTlQzSVBIMFdVb2ZnY2hlU21SNWFZOW5JVFZ6Tk1nRlRCZE1iMXZCLVNwM2tvSnJMV2t0bTUzWXl0YjloVFh0WEt2dXlrTFdtTnJCOFd4dklnbzVrLWI3U3Fubw?oc=5" target="_blank">La première photo du roi Mohammed
📰 Le Desk · 08/09/2017
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxON0NId29kTUlLYXZOMnhkb1FGWlVEUkRYMk40MHlGdmp4eEFMakRfWnlZM0FSSjZ6Y05xdVZzN29tc0VzMnJMWTd1eU1vLWFDQjdZUkRCMEU5a1RmRGhZb01UWU8tbGhZeEhOMWh3SFNiQUNKREpIdlplMzNub042R0NfaFE?oc=5" target="_blank">n°199. La maladie du roi et la maladie du systèm
📰 Infomédiaire · 07/09/2017
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOZXZ5SktwRVFSMVZwaWdVaFRDSTNkQ0JVSzBBYmk5VHpFNktXZWhPcmNCd2xtUW1DOHJLeVpVbjZsWDViclRWUGxtRmt2TFlLTjJOSDR4X25Bb1h2Y2VjbG01UG0ydTBLQ3lYSkJRTWFaVk9aZG1PWjhGb0tWZGRwZmhtclJaTURrQlo5aVdjNXV5QQ?oc=5" target="_blank">Alerte : Le Roi Mohammed VI s
📰 Jeune Afrique · 06/09/2017
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxOWmN4WjRoc2ZoeGRiSG13ZWhHVUJVMk5lT0dwb1BJMFo5MDdrN2hhLVhDdWlRVHpCZVViMjcwNXA2bEg5Zy1DUzBmMmFCS2ZxdVBNdThGUnVNUm1LU2szd1lQZEFMWGtIb1M1ckhKSFp1S0xfdHRzWVpUZEVzR3cxQm1zdkoyejBib3FBZ2dUUHVpZ3BXLUo2WWZDTlpTWU54Und4S1NHZzNmZ3lTQU9TZGVYRWF2Nnk1OT
📰 Le Desk · 06/09/2017
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTWczMnFRT1NIUmlISlJ4ZG1pVmdWS1p4UEJscmJRR2dreGQxbDJkdDVUZFAxOG1Wb3JnSUZnaDNVRDRfdlJ5ZUthLTB4Zm90dlJiNHFBS2hfdjNKLVlmV29jTVdURVRDZEpURHRMcnc4NU5uSkc4TmJhMHBfQUlGMW14clNDWWRv?oc=5" target="_blank">Mohammed VI a subi une intervention chirurg
📰 Yabiladi.com · 06/09/2017
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPay1pUlVPMGg1Skl1anBPNHhxRGRrV3IyekRWWlVXODFoSS1UTHBvaE53TU5aYnEzU1VXc2dxUmNSd3pFVkxxaUlKMVdjRDdsb2JNcHF5bGhmRV9LcEJvaDFNSG9GLXBlbXFIUl96bEJMQ2tzRTgyUFMxWVU4SEIyX2ZYVHh0WXFTSFNlNkZCREtpdDJDNlZsUjI5OVM?oc=5" target="_blank">Le roi du Maroc
📰 Le360 · 06/09/2017
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNelJqZnRwZ0pya2xTRlZTOXhUQlNOYUdma0U5NTNidGlpWDBaX1NhNFo2OHVTYmxnVndONjNTazhPRXVDUWtXNWYwR29rSElJUmlOVld0c2V2QVJPN1gxcEcwZnVMOUx6MDNUS1JVSG5QV21jTEJuV000cEFDTGdjWjFQNjJJVUpEeXNXMTBLRm9taG1tOHFwTFgtNnNxdk0wT0hLLWxWRlQwUWx1MFpfTFBpUmc?oc=5"
📰 Telquel.ma · 06/09/2017
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOV0lnR3o4VEY2QUVRVWkyZzhpdTRTOGNkUGpFVldxTTNFVHM1MENwUUVvRTRaRTk0SXljekNZdUszNTFWS2JzVTQ3TDg4VXJBVWtRc2xGWDRnNk9qV3JZZmd1OV9kQzZ5cDFiX0dtM3VGWlBMVFlabEs4XzRGdUxLV1RRWEM0dVhRUHJMWmtwUzdtM3pWcWVUSUZXZUMwSUhDNmp2WjNCbldubm1f?oc=5" target="_bl
Health and quality of life outcomes · 2003
European journal of ophthalmology · 2012
Purpose. To determine the prevalence of ocular surface diseases and identify risk factors in a population of patients receiving antiglaucomatous eyedrops over the long term. Methods. An observational cross-sectional study was designed to investigate ocular surface signs and symptoms using simple clinical tools. An ocular surface disease intensity score was calculated based on 10 questions regarding ocular surface symptoms and signs with a 4-grade scale. Patients were classified into 3 groups (A, B, and C) according to this total score. A multinomial logistic regression was performed in order to identify risk factors for surface disease. Results. In an overall population of 516 patients, 49% belonged to group A, 30% to group B, and 21% to group C. The multivariate analysis showed that the following factors were correlated with the severity of ocular surface disease: patient age, number of daily eyedrops, past topical treatment changes for ocular intolerance (found in the history of 40% of the patients), intraocular pressure (found to be significantly higher in patients with more severe ocular surface disease), and glaucoma severity. Conclusions. Patients treated for primary open-angle glaucoma or ocular hypertension often have ocular surface diseases, more often and more severely in older patients receiving more drugs and presenting with more severe glaucoma. These high prevalence values might therefore have consequences on the burden of the disease in terms of adherence to treatment and quality of life.
Acta ophthalmologica · 2008
Abstract.Purpose: To validate a glaucoma‐specific health‐related quality of life (HRQoL) questionnaire: the Glau‐QoL©.Methods: Patients with ocular hypertension (OHT) or glaucoma took part in a cross‐sectional psychometric validation study (n = 573) and a separate reproducibility study (n = 244). Patients answered the 36‐item Glau‐QoL©, designed from in‐depth patient interviews.Results: The clinical validity of the Glau‐QoL© was excellent and clearly demonstrated that as disease severity and visual field impairment increased, HRQoL scores for the Psychological Wellbeing, Self‐image, Daily Life, Driving, Anxiety and Burden of Treatment domains were negatively affected. Increased age and lower visual acuity were also associated with lower HRQoL scores, although to a lesser extent than the previously mentioned criteria. Worsening of HRQoL domains correlated with the clinical stage of glaucoma: Anxiety and Burden of Treatment scores dropped noticeably when patients were first diagnosed and started treatment, followed by a decrease in scores for Driving, Daily Life, Psychological Wellbeing, and Self‐image as clinical conditions worsened. Psychometric validation showed acceptable convergent and discriminant validity of the Glau‐QoL©, and good reproducibility, with intraclass correlation coefficients (ICC) and concordance correlation coefficients (CCC) ≥ 0.69. Internal consistency reliability was high (Cronbach's α coefficients > 0.70) for the Daily Life, Psychological Wellbeing, Burden of Treatment and Driving domains; acceptable (coefficients of 0.65 and 0.68, respectively) for the Self‐image and Anxiety domains; and weak (coefficient = 0.58) for the Confidence in Health Care domain.Conclusions: The Glau‐QoL© questionnaire is a valid and specific HRQoL instrument that demonstrates excellent correlations with disease progression in patients with glaucoma and/or OHT.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Investigative ophthalmology & visual science · 2015 · Journal Article
Denis P, Aptel F, Rouland JF, Nordmann JP, et al.
Investigative ophthalmology & visual science · 2011 · Clinical Trial
Aptel F, Charrel T, Lafon C, Romano F, et al.
Clinical ophthalmology (Auckland, N.Z.) · 2010 · Journal Article
Nordmann JP, Baudouin C, Renard JP, Denis P, et al.
European journal of ophthalmology · 2009 · Comparative Study
Nordmann JP, Baudouin C, Bron A, Denis P, et al.
Journal of glaucoma · 2005 · Journal Article
Nordmann JP, Lafuma A, Deschaseaux C, Berdeaux G
Journal of glaucoma · 2019 · Journal Article
Penaud B, Leleu I, Laplace O, Akesbi J, et al.
Ophthalmology · 2016 · Journal Article
Borderie VM, Loriaut P, Bouheraoua N, Nordmann JP
European journal of ophthalmology · 2012 · Journal Article
Baudouin C, Renard JP, Nordmann JP, Denis P, et al.
JPRAS open · 2024 · Case Reports
Timoumi R, Moyal L, Nordmann JP, Bennedjai A
Case reports in ophthalmology · 2021 · Case Reports
Bennedjai A, Adam R, Akesbi J, Rodallec T, et al.
Retinal cases & brief reports · 2020 · Journal Article
Chafik K, Thibault R, Laura M, Amin B, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026 · Journal Article
Kaliche MN, Vienne-Jumeau A, Hallali G, Adam R, et al.
Acta ophthalmologica · 2015 · Case Reports
Jouve L, Akesbi J, Nordmann JP
American journal of ophthalmology · 2002 · Clinical Trial
Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, et al.
Journal of pediatric ophthalmology and strabismus · 2008 · Case Reports
Streho M, Roussat B, Bouaziz T, Ounnas N, et al.
Journal of pediatric ophthalmology and strabismus · 2003 · Case Reports
Laplace O, Voegtle R, Rigolet MH, Bourcier T, et al.
Acta ophthalmologica · 2008 · Journal Article
Béchetoille A, Arnould B, Bron A, Baudouin C, et al.
Health and quality of life outcomes · 2003 · Evaluation Study
Nordmann JP, Auzanneau N, Ricard S, Berdeaux G
American journal of ophthalmology · 2002 · Clinical Trial
Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, et al.
Case reports in ophthalmology · 2025 · Case Reports
Kaliche MN, Nordmann JP, Putterman M, Nguyen TH, et al.
Acta ophthalmologica · 2022 · Journal Article
Olivier R, Knoeri J, Leveziel L, Negrier P, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2018 · Journal Article
Moyal L, Blumen-Ohana E, Blumen M, Blatrix C, et al.
Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ©) in glaucoma using a qualitative study
Abstract Background Compliance is a major issue in glaucoma care. It is usually poor in glaucomatous patients, and may ultimately result in an acceleration of the disease progression and a risk of blindness. Reasons for
Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ©) in glaucoma using a qualitative study
Abstract Background Compliance is a major issue in glaucoma care. It is usually poor in glaucomatous patients, and may ultimately result in an acceleration of the disease progression and a risk of blindness. Reasons for
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Journal of glaucoma · 2010 · Journal Article
Kobelt G, Texier-Richard B, Buchholz P, Bron A, et al.
✨ Profil synthétique
IA · 22/05/2026Le Dr Jean-Philippe Nordmann est un rhumatologue libéral à Paris, avec une production scientifique significative dans le domaine de l'ophtalmologie. Son h-index de 22 et ses 79 publications reflètent son engagement dans la recherche. Ses travaux portent principalement sur les maladies oculaires et les thérapies associées.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.